Hüneke R, Fassl J, Rossaint R, Lückhoff A
Department of Anesthesiology, University Hospital, Rheinisch-Westfalische-Technische Hochschule (RWTH), Aachen, Germany.
Acta Anaesthesiol Scand. 2004 May;48(5):547-61. doi: 10.1111/j.0001-5172.2004.00391.x.
The focus of the present review is on how interference with various ion channels in the heart may be the molecular basis for cardiac side-effects of gaseous anesthetics. Electrophysiological studies in isolated animal and human cardiomyocytes have identified the L-type Ca(2+) channel as a prominent target of anesthetics. Since this ion channel is of fundamental importance for the plateau phase of the cardiac action potential as well as for Ca(2+)-mediated electromechanical coupling, its inhibition may facilitate arrhythmias by shortening the refractory period and may decrease the contractile force. Effective inhibition of this ion channel has been shown for clinically used concentrations of halothane and, to a lesser extent, of isoflurane and sevoflurane, whereas xenon was without effect. Anesthetics furthermore inhibit several types of voltage-gated K(+) channels. Thereby, they may disturb the repolarization and bear a considerable risk for the induction of ventricular tachycardia in predisposed patients. In future, an advanced understanding of cardiac side-effects of anesthetics will derive from more detailed analyses of how and which channels are affected as well as from a better comprehension of how altered channel function influences heart function.
本综述的重点是,干扰心脏中的各种离子通道如何可能成为气体麻醉剂心脏副作用的分子基础。对分离的动物和人类心肌细胞进行的电生理研究已确定L型钙通道是麻醉剂的主要作用靶点。由于该离子通道对心脏动作电位的平台期以及钙介导的机电耦联至关重要,其抑制作用可能通过缩短不应期促进心律失常,并可能降低收缩力。已证明临床使用浓度的氟烷可有效抑制该离子通道,异氟烷和七氟烷在较小程度上也有此作用,而氙气则无此作用。麻醉剂还会抑制几种类型的电压门控钾通道。因此,它们可能会干扰复极化,使易感患者有诱发室性心动过速的重大风险。未来,对麻醉剂心脏副作用的深入理解将来自于对哪些通道受到影响以及如何受到影响的更详细分析,以及对通道功能改变如何影响心脏功能的更好理解。